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IMPORTANCE OF INTELLECTUAL PROPERTY RIGHTS
The needfora clearintellectual propertyrightssystemthatrewards
creativityand ingenuity tospurtechnological developmentisa current
concernof bothdevelopedanddevelopingcountries. Thisisespecially
felt incountrieswithlimitedtechnological capabilitysincetechnological
flowsare a partand parcelof investmentsand financialdecisionson
sourcesof new inventions, productsandprocesses.
It is notsurprising, therefore,thatin manyinternational fora, issues
onpatentinginparticular,andIPR ingeneral,aredissected andarticu-
latedwithinthe contextof the needsof pooranddevelopingcountries
for betteraccessto technologies andfor a moresympatheticresponse
fromthe developedcountries whichwanta well-definedsystemof IPR
protectionto owners.Thus,the proposedInternationalCodeof Ethics
forthe Transferof Technology suggestsanapproachthatwillmitigate
the problems of underdevelopment by requesting thedevelopedcoun-
triesto considerthe technology needsoflessdevelopedanddevelop-
ingcountries withinthe framework ofthe"most-favored nationclause."
Onthe otherhand,developedcountrieswanttraderelatedmatterscor-
relatedwith IPR protectionwhichisstillthesubjectof intensivediscus-
sionsin international tradeforaandwhichwillcontinueto be so inthe
policyandtradeagendain theyearstocome.
Inthe UNCTAD Meetingheldafew monthsago,nonreciprocal rela-
tionships thatwilladjustthe IPR systemaccordingtothe levelof tech-
nologicalrequirements ofneedycountries werediscussed. Thethinking
of the developingcountries(whichbelieve thata reciprocalapproach
mustbe modifiedbecauseofthe disadvantaged circumstances of less
developedand developingcountries vis-a-visthe developedones)is
•,Paper presentedduringtheDOST-PlDSSeminar-Discussion on"lnt_lllectualPropertyRights:PolicyIssuesand
Pe_s" heldonDecember13,1991 attheExecutiveLounge.DOSTCompound, Bicutan,Taguig,MetToManila.
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still along this line. On the other hand, countries in our region cannot
ignore the fact that rewards are necessary for the owners of technolo-
gies and that business opportunities will expand when technology-ori-
ented companies are assured of IPR protection for their inventions or
intellectual property creations. Technology-owners often invest substan-
tial amounts of time and money for R&D which may be recouped in roy-
alty fees or licensing arrangements.
One of the instruments which protect the IPR isthe patent. A patent is
granted to an owner not only as a reward for a new invention but also as
an exclusive right of exploitation to launch the invention in the market
and to gain a market lead over those who have not incurred any R&D
expenditure toward a similar creation. Patents are incentives to the in-
vestment of human,• technical and financial resources in research and
development which may lead to commercial advantages should a viable
invention result from such research and development (Gurry 1989). A
review of the patent laws of some countries shows that there is a
vacuum in patent coverage. Current statutes, somehow, have not been
•updated to respond to the tremendous strides in technological develop-
ment. In biotechnology, for example, many countries have not yet en-
acted appropriate laws that will encompass new patentable inventions
arising from the creation of new life forms. In the absence of a clear lan-
guage in the statutes, issues are resolved through administrative or judi-
cial interpretation. When cases are elevated to the courts, judges and
lawyers enter the exciting world of sciences, weave through the intrica-
cies of formulas and laboratory findings while scientists unravel legal
concepts and situations as their researches/inventions are "judicially"
analyzed. Thus, there is a need for simple and clear laws on the
patentability of new life forms in many jurisdictions, taking into account
the diversities of the circumstances of each country.
THE UNITED STATES PATENT LAWS
While patents are universally recognized as instruments of owner-
ship, their legal scope varies depending on the statutes of each country
and the conventions or international agreements to which it is a signa-
tory.
The US Patent Law is one of the oldest in the world. Approved in-
1793, it underwent many amendments, but its broad scope has essen-
tially been retained. There are three types of patents available in the
United States: first, the utility patents covering processes, machines,
manufactures and compositions of matter; second, the patents for
plants, including mutants, hybrids and newly-found seedlings; and third,
the patents for designs (Office of Technology Assessment 1991).ANCOG: PATENTING ISSUES 159
A patent lasts for 17years.However,for patentclaims for a human
drug product, medical device, food or color additives that have Deen
reviewed for commercial availability or use by the US Food and Drug
Administration (FDA),the patent isextendible for another five (5) years
(OTA 1991)
The US Congress passedthe Plant Patent Act in 1930.The law ex-
tends patent protection to most new anddistinct asexually propagated
varieties. To date,this isthe only law passedbythe US Congresswhich
provides patent protection for living matter. So far, 6,500 patents for
plants have been issued (OTA 1991).
Forty yearsthereafter, Congresspassedthe Plant VarietyProtection
Act of 1970which provides protection_ for certaintypes of new,sexually
reproducible plant species. The US Department of Agriculture, upon
application andafter evaluation,issuesa plantvariety protectioncertifi-
cate on any novel variety of sexually reproducible plant. Other than in
the caseof fungi, bacteria,or fruit generationpatents,the novel variety
must have distinctiveness,uniformity,and stability(emphasissupplied).
Plant breederswho hold a certificate issued by USDA canexclude oth-
ers from selling, offering for sale, producing and reproducing a hybrid
from the variety, and importing or exportingthe protected variety, ex-
cept researcherswho will usethe protectedvariety to develop newvari-
etiesand farmers whoseprimaryoccupation is togrowcrops.
The leading case in the United States which touched on the
patentability of biotechnologicalprocessesand productsis Diamondv.
Chakrabarty(447U.S. 303,65b. Ed. 1441100S CE2204). Inthis case,
a microbiologist had genetically engineered a bacterium capable of
breakingdown multiple componentsof crude oil, a property possessed
by nonaturallyoccurring bacteria,andtherefore believedto have a sig-
nificant value in the treatment of oil spills.
Chakrabarty and an associate discovered that plasmids, which are
hereditary units physically separatefrom the chromosomesof the cell,
controlthe oildegradation abilitiesof certainbacteria. In particular,they
discovered plasmids capable of degrading camphor andoctane, two
components of crudeoil. Inthe work representedby the patentapplica-
tion atissue inthe case,Chakrabartydiscovereda processbywhich four
different plasmids, capableof degrading four different oil components,
could betransferred to,and maintained stablyin,a singlepseudomonas
bacterium, which by itself has no capacity for degrading oil. While the
Chakrabartycasewasbeforethe court,the methodfor biological control
of oil spills requiredthe useof a mixture of naturally occurring bacteria,
each capable of degrading one component of the oil complex. In this
way, oil isdecomposedintosimpler_ubstanceswhich canserve asfood160 JOURNAL OFPHILIPPINE DEVELOPMENT
for aquaticlife.However,forvariousreasons,onlya portion ofanysuch
mixedculturesurvivedto attacktheoilspill.Bybreakingdownmultiple
components of oil,Chakrabarty'sorganismpromiseda moreefficient
andrapidoil-spill control.
Whilethe PatentOfficeallowedthe processclaimsforthe methodof
producing the bacteria,the claimsto the bacteriathemselveswere re-
jectedby the examineronthe groundthatmicroorganisms were prod-
uctsof natureandthat,aslivingthings,theywere nota patentable sub-
jectmatterunderthe law.The UnitedStatesSupremeCourtruledthat
suchlive, human-mademicroorganisms area patentable subject mat-
ter because theyconstitute eithera "manufacture"ora"composition of
matter" withinthe meaningof the patentstatutes.The court further
statedthat =Congresscontemplatedthat the patent laws shouldbe
givenwidescope,andthe relevantlegislativehistory supportsa broad
construction, whilelawsof nature,physicalphenomenon, andabstract
ideasare notpatentable, respondent's claimisnottoa hithertounknown
naturalphenomenonbutto a non-naturallyoccurringmanufactureor
composition of matterandproductof humaningenuity havinga distinc-
tive name,characteranduse."
The rulingofthe US SupremeCourtinthe Diamondvs.Chakrabarty
casesubsequentlyopenedthe doorstobiotechnologists and otherre-
searcherswhosecreativityproduced=productsand processes" that
were registeredandgivenpatents.It alsoliberalizedthe scopeof the
definitionof patentableinventionsin Americanpatentjurisprudence,
usheringinan eraof patentability of biotechnological =inventions."
The US isa signatoryto the ParisConvention, the PatentCoopera-
tionTreaty,theBudapest TreatyandtheInternational Unionforthe Pro-
tectionof PlantVarieties.
MEXICAN PATENT LAWS
In Mexico,afterthe changesmadein 1987tothe LawonInventions
andMarks,whichremainedinforceuntilJune27, 1991,.protection was
affordedto patentedinventions for a periodof 14 yearscountedfrom
thedateof the grantof the patent.
The Law on the Promotionand Protectionof IndustrialProperty,
whichcame intoforceonJune28, 1991,providesthat patentshave a
term of 20 yearscountedfromthe dateonwhichtheywereappliedfor.
Thisnowmakesthe legalprotection of inventions in Mexicocompara-
ble to that availablein the mainindustrialized countries,enablingthe
countrytocompeteonconditions thatarenolessfavorable.
It shouldbe mentionedthat, comparedwiththe protectionalready
availableforinventions inMexicoin1942(orhalfa centuryago),thelifeANCOG:PATENTING ISSUES 161
of a patent under the new law is five years longer. Compared with the
legislation that precededit, thedurationof protection remainspractically
unchanged, as20 yearsfromthetimeofapplication and 14yearsfrom
the timeofthegrantare, inactualpracticeverysimilar terms(Villareal-
Gonda1991).
Mexican Law onBiotechnologicalInventions
The newLawonthe Promotion and Protection of Industrial Property
would,forthe fi_t time, allowthe grantingofpatentswhichtakeseffect
in 1997forinventions involvingthe following:
Q biotechnological processes andtheirproductsinthe industries
manufacturing pharmaceutical chemicals,medicinesin gen-
eral,foodsandbeveragesforanimalconsumption, fertilizers,
pesticides, weedkillers, fungicides andproducts witha biologi-
cal actionsuchashormonesandvaccines;





This provisionof the newlawsubstantiallyreducesthe numberof
technologicalareasthat are excludedfrom patent protection.It con-
formsto a trendthathasbeengoingon in manycountries, the funda-
mentalpurposeof whichisto giveequalstimulation in alltechnology-
relatedareasto investments inthe industrial development ofnewgroups
and manufacturingprocesses.
The newlawalsoprovidesthatnopatentsareto be grantedforthe
typesof invention thatinvolvelivematerialsforwhichthereisasyetno
international consensus astotheirpatentability. Specifically, patentswill
notbegrantedin Mexicofor animalspeciesorbreeds,genes,partsof
the humanbody,etc.Indeed,thepatentability ofbiotechnological inven-
tionsis confinedtothe typesof inventionmentionedabove regarding
whichthere isalreadysufficient familiarityandexperienceat the world
level.(The New MexicanLawonindustrialProperty,R. VillarealGonda,
WIPO, Geneva, November1991.)
OTHER COUNTRY PATENT LAWS
In india,the IndianPatentsACtof1970isbeingreviewedto consider
developments in biotechnology.The country recently established162 JOURNAL OFPHILIPPINE DEVELOPMENT
Biotechnology Consortium Ltd. to promote the transfer and commer-
cialization of biotechnology.
In Korea, they are deliberating on the.intemational joint research pro-
motion law to ensure biotechnology development and funds for R&D.
PHILIPPINE PATENT LAWS AND BILLS
Republic Act No. 165 is the present law regulatingthe issuance of
patents in the Philippines. Itwas enacted 44 years ago and had under-
gone six revisions, namely those under Republic Act Nos. 637, 864 and
5434, Presidential Decree Nos. 1263 and 1520, and Batas Pambansa
Big. 129.
Before R.A. 165 came intoforce on June 20, 1947, the controlling law
on patents was Act No. 2235 enacted bythe Philippine Legislature on
February 10, 1913. Act No. 2235 made the United States Patent laws
applicable in the Philippine Islands. Section 1 of this Act provides that
"owners of patent.., which have been issued or may hereafter be is-
sued, duly registered in the United States Patent Office under the laws
of the United States relating to the grant of patents, shall receive in the
Philippine Islands the protection accorded them in the United States
under said laws."
Inventions Patentab/e UnderAct No. 2235 and R.A. 165
The United States Act of Congress of March 3, 1897 which was
amendatory of section 4886 of the US Revised Statutes, declared as
patentable inventions:
•.. anynewandusefulart,machine,manufacture,orcomposition of mat-
ter,or any newandusefulimprovements thereof(29 Star L.,692, 2 Fed.
Stat.Ann., 2nd ed., p.23)
The legislative history of the foregoing provision may betraced tothe
Patent Act of 1793 authored bythe very distinguished American states-
man and jurist Thomas Jefferson. On February 10, 1913, this same pro-
vision entered the Philippine legal system through the enactment into
law of Act No. 2235.
When Republic Act No. 165 came into effect in 1947, the following
under Section 7 thereof became the new definition of patentable inven-
tions, viz.:
Any invention of a new and useful machine,manufacturedproductof
substance,process,oran improvementofanyofthe foregoing.ANCOG: PATENTING ISSUES 163
It might be noted thatthe Philippine Congressthat enacted Republic
Act No. 165 modified the provisionof the American statute which con-
tained the words art, composition of matter, and substituted "manufac-
tured product" for the word manufacture. The American Law does not
have the word =process" which isexplicitin the Philippine Law. One can
assume, therefore, that in the Philippines, patent application for a proc-
ess may bejustified since the law already providesfor this. In any event,
steps have been taken to cladfy Section 7 of R.A. 165.
Pending Bills Amending Section 7 of R.A. 165
During the Second Regular Session of the present Congress, the
House of Representatives passed on firstreading House Bill No. 24489
which isAn Act ilnstitutingand OrdainingAn Intellectual Property Code
sponsored by Congressmen Yap (J.), Yap (R.), Romualdo, Cua and
Romero.
Chapter Ii1_Section One, Article 84, of House Bill No. 24489 reads:




withthe intervention ofhumaningenuityshallalsobe patentable.
Essentially, the first paragraph is a restatement of the present law.
However, it is interesting to note that the authors of the bill made it an
important matter to add another paragraph onthe scope ofwhat may be
patented. Clearly, there is already a tacit recognition by the authors
themselves of the need to includethese =newstrainsof microorganisms
or of any other living matter produced with the intervention of human
ingenuity" to widen the scope of the definition ofwhat subject matters
should be patented. To put it conversely, the authors give the impres-
sionthat the present law on patents does notinclude these "new strains
of microorganisms." However, the Bureau of Patents, Trademarks and
Technology Transfer (BPTTT) accepts patent applications for
biotechnological products and processes. The stand of the BPTTT is
anchored on the accession of the Philippines to the Budapest Treaty,
discussed in the later part of this paper, which establishes the mecha-
nisms and guidelines for the deposit of microorganisms in authorized
intemational depositories.
Meanwhile, the Senate passed during the Second Regular Session
on first reading a counterpart bill introducedby Senator Laurel which is164 JOURNALOF PHILIPPINEDEVELOPMENT
An ActRevisingRepublic Act 165,As Amended,OtherwiseKnownAs
the PatentLaw. Section4 of Senate BillNo.998 reads:
Inventions patentable. - Any new technical solution of a problem in any
field of human activitywhich involves an inventive step and is industrially
applicable shall be patentable. It may be, or may relate to, a machine,
product, or process, or an improvement of any of the foregoing.
On the other hand, Section 5 of Senate Bill No. 998 explicitly enu-
merates the nonpatentable areas which are as follows:
(a) discoveries, scientific theories and mathematical methods;
(b) schemes, rules and methods of performing mental acts, playing
games or doing business, and programs for computers;
(c) methods for treatment of the human or animal body by surgery or
therapy and diagnostic practices on the human or animal body. This
provision shall not apply to products for use in any of those methods;
(d) plant or animal varieties or essentially biological process for the pro-
duction of plants or animals. This provision shall not apply to micro-
biological processes and the products of said processes (underscor-
ing supplied);
(e) aesthetic creation;
(f) a substance used as medicine which is a mere mixture of two or more
known ingredients or of a process for producing such by mere ad-
mixtures; and
(g) anything which is contrary to public order or morality.
Senate Bill No. 998, like House Bill No. 24489, contains expansive
definitions of patentablematters. There seems to be a consensus




patentableinventions "plantoranimalvarietiesor essentially biological
process[es]for the production of plantsor animals"(firstsentenceof
Section5[d]).However,microbiological processesand the productsof
the saidprocessescanbethe propersubjectsof a patentsinceSection
5 is notapplicabletothem.
As regardsprotectionfor plantand animal breeders,Chapter 7 of
H.B.24489 provides forthegrantingof protection to newplantvarieties
oranimalbreeds.Article165,ChapterVII, ofthe said billprovides:ANCOG:PATENTING ISSUES 165
"GrantandRequisites ofProtection." Protection shallbegranted inac-
cordance withthisChapter toanynewvariety ofplantoranynewanimal
breed which isstableandhomogenous asherein defined.
The protection grantedunderthischapteris notthesame asthatof
patentsgrantedbutthe rightsthereinarecloselysimilartothoseof the
latter.The scopeof protectionfor plantandanimalbreedsconsistsof
the exclusiverighttothe production of the propagating materialof the
protectedvariety.Article170thereofprovides:
"ScopeofProtection"- Upon thegrantofprotection under thisChapter,
noonemay,without theconsent oftheholder oftherightofprotection,
produce propagating material oftheprotected variety withaviewtomar-
keting, offering forsaleorselling itinthecourse ofbusiness, normay
anyone otherwise distribute material totheprejudice ofthetitleholder.
As in patents, the rightto protectionof a variety belongsto the
breederor discoverer,or hissuccessor in interest.Whentwoor more
personshave bredorjointlydiscovered a variety,the rightshallbelong
to themjointly.In casetwoor more personshave bredor discovered
separatelyandmadejointlya variety,the personwhocanprovethathe
wasthefirstbreederordiscoverer willhavethe rightof protection butif
theyhappenedto havedoneitsimultaneously, the first-to-fileruleshall
be applicable.The rightof protection isrepresented bya "Titleof Pro-
tection",whichissimilartoa letterspatent.Unlikepatents,however,the
life of protectionfor plantandanimalbreedslastsonlyfor fifteen (15)
yearsand eighteen(18) yearsinthe caseof vineandtrees. Forsome
speciesor groupsof plants,the IntellectualPropertyCommission (cre-
atedunderthe bill)mayextendthe periodbyfive (5) years.
The distinctionbetweenpatentsfor inventionand the protection
grantedto plantand animalbreedsunderH.B. 24489 is an important
aspectof moderndevelopment inIPR.Itwillbehelpful torememberthis
in orderthatthe laymanwillnotbeconfusedbetweenthe twoformsof
IPR protection onthe proposedbill.
Modern Trendsin IPR Protectionin Biotechno/ogy
As mentionedearlier,the BPTTT alreadyacceptsapplicationsfor
patentingof biotechnological mattersdespitethe factthatthe billdeal-
ingwiththeseareasisstillpendinginthelegislature. Thejustification for
suchpracticeisthe factthatthe currentpatentlaw,R.A. 165, doesnot
expresslyexcludebiotechmattersas amongthosenotpatentable.As
mentionedalso,the factthatthe Philippines isa signatory tothe Buda-166 JOURNALOF PHILIPPINEDEVELOPMENT
pestTreatybuttresses the factthatthe patentmaybeavailabletosuch
matters.Moreover,theChakrabarty casehasa persuasiveeffectinthis
jurisdiction and maybe usedbythe BPTi-i asbasisfor itsview.
Nevertheless,the patentabilityor nonpatentability of lifeforms b and
otherbiotechnology productsand processes remainsas a majorissue
for debatein the international arena.There are markeddifferencesin
theviewsof IPRexpertsandbiotechnologists fromdifferentpartsof the
world.
In an April 5, 1978 decisionin Germany,for example,the Federal
PatentCourtof Germanyactedfavorablyona patentclaimfor agroup
of naturaloccurringorganismscalled"lactobacillus bavadcus." The
claimdefinedthe microorganisms asobtainablebyproduction ofbacte-
r/a bycarryingoutcertainspecified selectionstepsthatresultinthepro-
duction of bacteriawhichpredominantly produce theL(+)sourcesof lac-
tic acid.Althoughnaturallyoccurring, the newmicroorganisms hadpre-
viouslybeen undiscovered andrequiredhumantechnicalintervention
to recognizeandproducethem.ThisGermandecisionseemsto be in
conformity withthe "specialcharacteristics of the microorganism"rule
inthe Diamondvs. Chakrabartycase(Strauss1985).
The Canadianrulingonthe matterwasfirstformulatedbythe Cana-
dianAppealsBoardinthe caseof In re: Abitibi datedMarch18, 1992.
The Boardsaidin thiscasethat=aninventorwho createsa new and
unobvious insectwhichdidnotexistbefore(andthisisnota productof
nature)andcanrecreateituniformly andat will,and itisuseful(tode-
stroythe specieof budworm),thenitiseverybita newtoolof man asa
microorganism." Notethatthe Boardbaseditsdecisiononwhat itper-
ceivedasthe noveltyandusefulness ofthe insect.However,according
to the courtsin somecountries,the noveltyof microorganisms canbe
basedonthe factthatthoseskilledintheart arenotawareoftheirexist--
ence,despitethe fact thattheyhave beeninnatureallalong.Microor-
ganismsand suchother substances,accordingto experts,appear in
natureinvery complexsurroundings whichdonotallowdirecttechnical
useto bemadeof them.Insuchcases,therefore,the meritof the claim
is to be seen in the originalisolationandidentificationof the product,
providing an indication of itsindustrial application andmakingthe prod-
uctavailabletothe public(Strauss1985).Suchcriteriawere alsoused
asoneof the basesfora USdecisionwhichdeclaredthatplants,seeds
and planttissueculturesresulting fromanentirelynewbiotechprocess
are patentable(Ex ParteHibberd,227 USPG 443).
On the otherhand,whilethe processitself isgenerallyconsidered
patentable,itsresultmaynot necessarilybe so.The EuropeanPatent
Officehassetasoneof itsguidelines, that"substances freelyoccurringANCOG:PATENTINGISSUES 167
in nature...[are] mere discoveryand thereforeinpatentable. Howeverlif
a substancefoundin naturehasfirstto be isolatedfromthe surround-
ingsanda process for obtainingitisdeveloped,thatprocessispatent-
able."In fact,in 1989itgranteda patentinfavorof LubregalGenetics,
covennga processforthe rapiddevelopmentof hybddplantsandfor




However,despitethe granting of biotechpatentsinseveralcountries
inthe world,therearestillthosewhomaintain thatbiotechproducts and
processes donotactuallyfallunderthe categoryofpatentablematters.
Accordingto them,the patentlawsthat evolvedduringthe Industrial
Revolutionin Europewere envisioned to protectmachinesand inven-
tionsthat were normallyusedfor the production system.Suchlaws,
therefore,werenotcontemplated toapplyto products, especially those






the self-replication ofthe hostorganism.
One of the problemsinthe patentingof microorganisms isthe diffi-
cultyofdescribing accuratelythe invention inwritingtocomplywiththe
requirementthata patentapplication disclosethe invention sothatone
skilledinthe artcancarryitout.Thereare, likewise, moralityandpublic
orderissuesinvolved.
HIGHLIGHTS OF THE BUDAPEST TREATY
The Budapest Treatyprovidesthatthecontracting stateswhichallow
or authorizethe depositof microorganisms forthe purposeof patent
procedures shallrecognize forsuchpurpose deposits ofmicroorganisms
with anyinternational depository authority. The Treatyfurtherprovides
that the recognition shallincludethe acknowledgment of the fact and
dateofthe depositasindicatedbythe intemational depositoryauthority
aswell asa recognition ofthe factthatwhatisfurnished asa specimen
isa sampleofthe depositedmicroorganism (Article3, ChapterI).
The depositcomplements a writtenspecification or description of a
sample,whichfor patentingpurposesconstitutes compliance with the
requirementofaccuratedescription ofthe microorganism beingsought
tobepatented.TheBudapest Treatyfacilitates the patenting ofmicroor-168 JOURNALOF PHILIPPINEDEVELOPMENT
ganisms among members of the Unionor member-countries acceding
to the Treaty.
UnderArticle6 ofthesaidTreaty,apublicinstitution acquiresthesta-
tus of an International Depository Authorityunderthe followingcondi-
tions,viz.:
(a) Thedepository institution mustbelocated intheterritory of a con-
tracting Stateandmustbenefit fromassurances furnished bythat
State totheeffect thatthesaidinstitution complies andwillcontinue
tocomply withcertain requisites;
(b) Thesaidassurances mayalsobefurnished byanintergovernmental
industrial property organization: inthatcase, thedepository institu-
tionmustbelocated intheterritory ofamember-State ofsaid organi-
zation.
Furthermore,adepository institution whichservesasan International
Depository Authoritymustmeetthe followingrequirements:
(a) Itmusthavea continuous existence;
(b) Itmusthavethe necessarystaffandfacilities,asprescribedin
the Regulations,to performitsscientificand administrative
tasksunderthe Treaty;
(c) Itmustbe impartialandobjective;
(d) Itmustbeavailableforthe purposes of depositto anydeposi-
torunderthe sameconditions;
•(e) It mustacceptfor depositanyor certainkindsof microorgan-
isms,examinetheirviabilityandstorethem as prescribedin
the Regulations;
(f) itmustissuea receipttothedepositor andanyrequiredviabil-
itystatementas prescribed inthe Regulations;
(g) It mustcomply,in respectof the depositedmicroorganisms,
withthe requirementof secrecyas prescribedin the Regula-
tions;and
(h) Itmustfurnishsamplesof anydeposited microorganism under
the conditionsand in conformitywith the procedurespre-
scribedinthe Regulations.
CONCLUSION
Developingcountrieslike the Philippinesshouldbe alerted to the
developmentsin patentingespeciallyinthe field of biotechnologyin
•advancednationswhichare presentlythe principalsourcesof high-
biotechnology R&D.Withouta reasonableIPR protection,itisalmostaANCOG:PATENTINGISSUES 169
foregoneconclusion thatthesenations wouldnotsharethe resultsand
fruitsoftheirR&D efforts. ;-_
Atthe nationallevel,the activeparticipation of the government,the
pdvatesector,the academe,andthe entirelocalscientificcommunity
mustbeforgedinthe presentation of policyproposals thatwillbe incor-
poratedin a new IntellectualPropertyCode of the Philippines. Specifi-
cally,the localscientific communityshouldhelpinthe formulationand
clarification ofpolicyissuessuchasthoseinvolving the first-to-filerule
vis-a-visthe first-to-inventruleunderRepublicAct No.165whichvery
few countriesstilladhere to, notablythe Philippinesand the United
States.
Furthermore,the scope and coverage of the existingintellectual
propertyrightslawsmustbe redefinedto keeppace withmodemtech-
nologicaltrends.The definitionofwhatarepatentableinventions under
our presentpatentlawneedsa clearerreformulationsothatshadesof
doubtonthe patentability or nonpatentability of someinventions could
bedispensed with. Inaddition,betterincentives andrewards fordeserv-
ing inventorsshouldbegiven.
Thereisa pressingneed,then,for a national dialogueamongallsec-
tom encompassing the government,the privatesector,the academe,
andthescientific communityingeneralfor aconsolidated nationalposi-
tiononimportantpatentingissues.Inadopting a multisectoral approach,
itisimperativethatwe consider the followingactions:
(a) Developthe capability of scientists and institutions to acquire
knowledgeandinformation onIPR andcurrenttrends;
(b) Developandenhancethe capacityofscientists, policymakers,
andR&Dexecutivestonegotiate forfavorabletechnology ac-
quisitionandtransfercontracts;
(c) Explorethe commercialbenefitsfrominventions andresearch
outputs withappropriate IPR protection.





ize regularforafor discussions of IPRdevelopments.
In thisregard,the STCC hascreateda multisectoral Committeeon
IntellectualPropertyRightsthroughSTCC ResolutionNo. 2, seriesof
1992. Due to the emergingdevelopmentsin IPR protection,the said
committeewascreatedtostudycurrentIPR issues,including proposed170 JOURNALOF PHILIPPINEDEVELOPMENT
•legislation onthe subject,andtocomeupwitha clearnationalconsen-
susthatwillfurtherpromotethe statepolicytoprotectthe dghtsof Fili-
pinoscientists,inventors,artists,andothergiftedcitizenstotheir intel-
lectualproperties and creations.Itis alsoone of the objectivesto en-
hancethe awareness of Filipinoscientists, inventorsandresearchersof
theirintellectualpropertyrights whichwillcontribute tothedevelopment
of S&T and of the economyas a whole, as well as to promotethe
availmentof theirservices.
The membershipof the Committeeiscomposedof representatives
fromthegovernment, the academeandtheprivatesector.Ithasalready
been organizedwith representatives fromthe Departmentof Science
and Technology(DOST) and the Departmentof Trade and Industry
(DTI) as co-chairmen. Ithasdivideditselfintothreeareasof concerns:
the industrial sector; health, pharmaceutical and nutrition; and
biotechnology andadvancedtechnology. Onememberof the Commit-
teewaschosentoactascoordinator for eachofthethreeareasofcon-
cern.
Withthe creationof the IPR Committee,it ishopedthata clear na-
tionalposition onIPRissues willbeformulated to enablethe Philippines
tofirmupitsstandonthematter,especiallyontheGAI-F agreement.In
thisregard,one of the activitieslinedupisto organizea workshopto
threshoutthedifferences inthe positions ofthemembersof thescience,
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